We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer

News   Apr 06, 2009

 
Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
 
 
 

RELATED ARTICLES

Green Tea Acts as a "Remote Control" To Switch on Cell Therapy

News

In a new study published today in Science Advances, researchers from East China Normal University have created an elegant system for activating genetically edited cells using green tea.

READ MORE

What Puts the "Fire" in Fire Ants?

News

Researchers have identified pyridine alkaloids that, along with other venom components, could contribute to the serious medical problems caused by fire ant stings.

READ MORE

Genes Linked to Sex Ratio Associated With Infertility

News

"Is it a boy or girl?". It's presumed that there's a 50-50 chance you'd have one or the other. However, a new study of the sex chromosomes suggest they genes which, at least in mice, skew that assumed ratio to favor one sex, could have major implications for male infertility.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE